1Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke, the European Cooperative Acute Stroke Study(ECASS)[J].JAMA, 1995, 274(13): 1017-1025.
2Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group[J]. N Engl J Med, 1995, 333(24): 1581-1587.
3Hacke W, Brott T, Caplan L, et al. Thrombolysis in acute ischemic stroke:controlled trials and clinical experience [J]. Neurology,1999,53(7 Suppl 4): S3-S14.
4Wardlaw J, Warlow C. Thrombolytic therapy for acute ischaemic stroke-The updated Cochrane database of systemic reviews meta-analysis[J]. Cerebrovasc Dis, 1999, 9: 124.
5Wardlaw JM. Overview of Cochrane thrombolysis meta-analysis [J].Neurology, 2001, 57(5 Suppl 2): S69-S76.
6Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment:pooled analysis of ATALANTIS,ECASS,and NINDS rt-PA stroke trials [J]. Lancet, 2004, 363(9411): 768-774.
